Events

Target Audience
This program is intended for dermatologists and NPs, PAs, and nurses who practice in dermatology.

Learning Objectives
Upon completion of this activity, participants should be able to:

Improving Management of Atopic Dermatitis in Children and Adults: Novel Therapies, Transition of Care, and Healthcare Disparities

• Identify patients who may benefit from new and emerging therapies for atopic dermatitis based on patient factors and drug safety and efficacy
• Discuss the components, goals, and benefits of an effective transition from pediatric to adult atopic dermatitis care with adolescent and young adult patients and their caregivers
• Apply strategies to address healthcare disparities in clinical practice to improve the management of atopic dermatitis

Recent Advances in the Management of Pustular Psoriasis

• Identify patients with pustular psoriasis early in the course of disease
• Describe the pathophysiology of pustular psoriasis and how it is different from that of plaque psoriasis
• Apply recent evidence of emerging agents into the clinical context of evolving paradigms in the field of pustular psoriasis treatment

Exploring New Diagnostic and Therapeutic Possibilities in Chronic Spontaneous Urticaria

• Formulate an appropriate diagnostic workup and potential treatment plan for patients with chronic spontaneous urticaria

Prurigo Nodularis: A Look at What’s to Come

• Apply best practices for diagnosing prurigo nodularis and identifying patients who may benefit from emerging therapies

Enhancing Care in Moderate to Severe Psoriasis: Treatment Selection, Medication Adherence, and Healthcare Disparities

• Describe the efficacy and safety profiles of current and emerging therapies for the treatment of moderate to severe psoriasis
• Develop treatment regimens for patients with moderate to severe psoriasis based on treatment characteristics and patient preferences
• Demonstrate cultural competence in addressing patient-specific needs in patients with psoriasis and skin of color

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Joint Accreditation Statement

In support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

Nursing contact hours: 5.50, which includes 5.50 hours of pharmacology credits

AAPA Credit Designation

Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the

IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 5.50 Interprofessional Continuing Education (IPCE) credits for learning and change.